← SynDRA
NAFADOTRIDE
SynDRA canonical compound SYN0001549 — structure-anchored drug synonym record
| Clinical phase | Preclinical |
| Primary target(s) | DRD3 |
| Mechanism of action | Dopamine receptor antagonist |
All known targets
Mechanisms of action (all sources)
- Dopamine receptor antagonist
- HTR1A FULL AGONIST
- DRD2 ANTAGONIST
- DRD3 ANTAGONIST
- DRD4 ANTAGONIST
- HTR1A AGONIST
Drug classes
Cross-references
Synonyms
- (+-)-nafadotride
- N-[(1-BUTYL-2-PYRROLIDINYL)METHYL]-4-CYANO-1-METHOXY-2-NAPHTHALENECARBOXAMIDE
- N-[(1-butylpyrrolidin-2-yl)methyl]-4-cyano-1-methoxynaphthalene-2-carboxamide
- CHEMBL286252
- CHEBI:64191
- A1-01951
- SMR000466292
- AC1MPBUT
- GTPL44
- MLS000758952
- MLS001424218
- SCHEMBL635866
- DTXSID1042603
- CTK8H0240
- MolPort-023-276-076
- HMS3394A15
- HMS3267P15
- HMS2232B11
- HMS2052A15
- HMS3370D02
- BCP27779
- BDBM50133923
- AKOS024257976
- TRA0072321
- CCG-101119
- NC00369
- SAM001247092
- CPD000466292
- LS-186981
- LS-187623
- RefChem:164395
- DTXCID9022603
- JP25MZ26IQ
- orb1738938
- SCHEMBL31555135
- HMS3414K11
- HMS3678K11
Look up NAFADOTRIDE in the interactive SynDRA portal →